← Leaderboards
Will Ryan Gutekunst
University Of California Santa Barbara
$1,937,963
Attributed
$1,937,963
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $360.9K · FY2013–23$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,937,963 · 2
By mechanism
R35$1,794,783 · 1
F32$143,180 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Santa Barbara
Same institution · by research overlap
- Bruce H. Lipshutz$4,289,447
- Joel H. Rothman$18,673,223
- Liming Zhang$5,943,691
- Thomas C Bruice$3,471,206
- Molly J Kirk$221,404
Others in their field
Top investigators on “Monomer”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Barton F Haynes · Duke University$35,141,575
- Anthony O Caggiano · Cognition Therapeutics, Inc.$29,520,445
- Marc A Hillmyer · University Of Minnesota-Twin Cities$21,273,165
- Robert F Garry · Scripps Research Institute, The$20,334,343
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$15,644,138
Research focus
MonomerVertebral ColumnDesignPolymersProgramsReactionStructurePharmaceutical ChemistryOrganismFamilyModernizationChemical ReactionChemistryLigationArchitectureLocationBiological SystemsInnovationBiologyDissectionBiomaterial CompatibilityExcisionFlexibilityAlkenes
Grant awards (8)
A Versatile Polymer Platform for Biomedical Applications$359,055
R35 · FY2023 · GM · contact PI
A Versatile Polymer Platform for Biomedical Applications$360,717
R35 · FY2022 · GM · contact PI
A Versatile Polymer Platform for Biomedical Applications$360,939
R35 · FY2021 · GM · contact PI
A Versatile Polymer Platform for Biomedical Applications$358,295
R35 · FY2020 · GM · contact PI
A Versatile Polymer Platform for Biomedical Applications$355,777
R35 · FY2019 · GM · contact PI
Development of Sequence Controlled Polymers for Antibacterial Therapeutics and Co$44,536
F32 · FY2015 · GM · contact PI
Development of Sequence Controlled Polymers for Antibacterial Therapeutics and Co$51,530
F32 · FY2014 · GM · contact PI
Development of Sequence Controlled Polymers for Antibacterial Therapeutics and Co$47,114
F32 · FY2013 · GM · contact PI